\
&
Contact us
\
&
Contact us
Published on | 5 months ago
Programmes Horizon Europe HorizonEU L+F H2020 L+FThe Commission published their recent report based on analysis of implementation data and feedback from surveys.
A summary is also available here.
According to the Commission, the new report confirms that:
The report describes the state of play in early 2024, with nearly 1 400 lump sum grants signed and many of them completed.
The previous assessment of lump sum funding was published in 2021
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Culture and society Agro-Food, Environment Missions
The TIDAL ArtS project is funded under the Mission for clean oceans and inland waters and combines the power of art and science to inspire action for our ocean and waters. In april they will publish a Lighthouse call for proposals of up to 15.000 euro per artistic work. The aim of the project is notably to create public art and raise awareness on... read more
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
